Role of parathyroid intervention in the management of secondary hyperparathyroidism

Nephrology Dialysis Transplantation

Volumn 18, Issue SUPPL. 3, 2003, Pages

  Fukagawa, Masafumi ^a   Nakanishi, Shohei ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hyperparathyroidism; Parathyroid hyperplasia; Parathyroid intervention; Parathyroidectomy; Percutaneous ethanol injection therapy; Ultrasonography

Indexed keywords

ALCOHOL; CALCITRIOL; CALCIUM CHANNEL STIMULATING AGENT; PHOSPHATE BINDING AGENT; VITAMIN D DERIVATIVE;

ARTICLE; DRUG EFFICACY; ECTOPIC TISSUE; HUMAN; MEDICAL DECISION MAKING; NODULAR HYPERPLASIA; ORGAN SIZE; PARATHYROID GLAND; PARATHYROIDECTOMY; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY; SECONDARY HYPERPARATHYROIDISM;

CALCITRIOL; CALCIUM CHANNEL AGONISTS; DIET; ETHANOL; HUMANS; HYPERPARATHYROIDISM, SECONDARY; HYPERPLASIA; PARATHYROID GLANDS; PARATHYROIDECTOMY; PHOSPHATES; VITAMIN D;

EID: 0038015186     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Hruska KA, Teitelbaum SL. Renal osteodystrophy. N Engl J Med 1995; 333: 166-174
2. Slatopolsky EA, Weerts C, Thielan J, Horst R, Harter H, Martin KJ. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients. J Clin Invest 1984; 74: 2136-2143
3. Martin KJ, Gonzalez EA, Gellens M, Hamm LL, Abboud H, Lindberg J. 19-Nor-1-α-25-dihydroxyvitamin D2 (paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis. J Am Soc Nephrol 1998; 9: 1427-1432
4. Hirata M, Katsumata K, Masaki T et al. 22-Oxacalcitriol (OCT) ameliorates high turnover bone and marked osteitis fibrosa in rats with slowly progressive nephritis. Kidney Int 1999; 56: 2040-2047
5. Goodman WG, Hladik GA, Turner SA et al. The calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism. J Am Soc Nephrol 2002; 13: 1017-1024
6. Slatopolsky EA, Burke SK, Dillon MA. RenaGel, a non-absorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone. Kidney Int 1999; 55: 299-307
7. Drüeke TB. The pathogenesis of parathyroid gland hyperplasia in chronic renal failure. Kidney Int 1995; 48: 259-272
8. Ureña P, Vernejoul MC. Circulating biochemical markers of bone remodeling in uremic patients. Kidney Int 1999; 55: 2141-2156
9. Katoh N, Nakayama M, Shigematsu T et al. Presence of sonographically detectable parathyroid glands can predict resistance to oral pulse-dose calcitriol treatment of secondary hyperparathyroidism. Am J Kidney Dis 2000; 35: 465-468
10. Åkerstrom G, Malmaeus J, Grimelius L, Ljunghall S, Bergstrom R. Histological changes in parathyroid glands in subclinical and clinical renal disease. Scand J Urol Nephrol 1984; 18: 75-84
11. Fukuda N, Tanaka H, Tominaga Y, Fukagawa M, Kurokawa K, Seino Y. Decreased 1,25-dihydroxyvitamin D3 receptor density associated with a more severe from of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 1993; 92: 1436-1443
12. Fukagawa M, Kitaoka M, Yi H et al. Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients. Nephron 1994; 68: 221-228
13. Tominaga Y, Tanaka Y, Sato K et al. Recurrent renal hyperparathyroidism and DNA analysis of autografted parathyroid tissue. World J Surg 1992; 16: 595-603
14. Tominaga Y, Tanaka Y, Sato K, Nagasaka T, Takagi H. Histology, pathophysiology, and indications for surgical treatment of renal hyperparathyroidism. Semin Surg Oncol 1997; 13: 78-86
15. Almaden Y, Hernandez A, Torregrosa V et al. High phosphate level directly stimulates parathyroid hormone secretion and synthesis by human parathyroid tissue in vitro. J Am Soc Nephrol 1998; 9: 1845-1852
16. Brown AJ, Ritter CS, Finch JL, Slatopolsky EA. Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: role of dietary phosphate. Kidney Int 1999: 1284-1292
17. Fukagawa M, Kitaoka M, Kurokawa K. Value of parathyroid sonography in secondary hyperparathyroidism [letter]. Nephrol Dial Transplant 1997; 12: 2461
18. Onoda N, Kurohara S, Yoneshima H. Usefulness of ultrasonographic power-Doppler imaging of parathyroid hyperplasia in renal hyperparathyroidism [abstract]. J Am Soc Nephrol 1998; 9: 569A.
19. Fukagawa M, Kitaoka M, Inazawa T, Kurokawa K. Imaging of the parathyroid in chronic renal failure: diagnostic and therapeutic aspects. Curr Opin Nephrol Hypertens 1997; 6: 349-355
20. Fukagawa M, Tominaga Y, Kitaoka M, Kakuta T, Kurokawa K. Medical and surgical aspects of parathyroidectomy. Kidney Int 1999; 56 [Suppl. 73]: S65-S69
21. Tominaga Y. Surgical management of secondary hyperparathyroidism. Am J Med Sci 1999; 317: 390-397
22. Norman J, Chheda H. Minimally invasive parathyroidectomy facilitated by intraoperative nuclear mapping. Surgery 1997; 122: 998-1003
23. Kitaoka M, Fukagawa M, Ogata E, Kurokawa K. Reduction of functioning parathyroid cell mass by ethanol injection in chronic dialysis patients. Kidney Int 1994; 46: 1110-1117
24. Kakuta T, Fukagawa M, Fujisaki T et al. Prognosis of parathyroid function after successful percutaneous ethanol injection therapy (PEIT) guided by color Doppler flow mapping in chronic dialysis patients. Am J Kidney Dis 1999; 33: 1091-1099
25. Kitaoka M, Fukagawa M, Kurokawa K. Direct injection of calcitriol into parathyroid hyperplasia in chronic dialysis patients with severe parathyroid hyperfunction. Nephrology 1995; 1: 563-568
26. Shiizaki K, Hatamura I, Narukawa N et al. Ultrasound-guided direct maxacalcitol injection into parathyroid glands in chronic dialysis patients with severe secondary hyperparathyroidism: induction of apoptosis in hyperplastic parathyroid cells [abstract]. J Am Soc Nephrol 2001; 12: 773A.
27. Numano M, Tominaga Y, Uchida K, Orihara A, Tanaka Y, Takagi H. Surgical significance of supernumerary parathyroid glands in renal hyperparathyroidism. World J Surg 1998; 22: 1098-1102
28. Goodman WG, Goldin J, Kuizon BD et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000; 342: 1478-1483